Connor, Clark & Lunn Investment Management Ltd. X Biotech Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$26 Billion
Q2 2025

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in X Biotech Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 48,274 shares of XBIT stock, worth $122,615. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,274

Previous 65,185 25.94%

Holding current value

$122,615

Previous $211,000 32.23%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	SELL	$2.56 - $3.36 $43,292 - $56,820	-16,911 Reduced 25.94%	48,274 $143,000
Q1 2025 May 12, 2025	SELL	$2.99 - $4.48 $26,936 - $40,360	-9,009 Reduced 12.14%	65,185 $211,000
Q4 2024 Feb 10, 2025	SELL	$3.8 - $8.25 $5,779 - $12,548	-1,521 Reduced 2.01%	74,194 $293,000
Q3 2024 Nov 08, 2024	SELL	$5.55 - $7.95 $11,144 - $15,963	-2,008 Reduced 2.58%	75,715 $585,000
Q2 2024 Aug 09, 2024	BUY	$4.54 - $9.89 $1,407 - $3,065	310 Added 0.4%	77,723 $399,000
Q1 2024 May 09, 2024	BUY	$4.03 - $8.13 $54,276 - $109,494	13,468 Added 21.06%	77,413 $629,000
Q4 2023 Feb 09, 2024	SELL	$3.56 - $4.65 $1,327 - $1,734	-373 Reduced 0.58%	63,945 $255,000
Q3 2023 Nov 13, 2023	BUY	$4.02 - $5.81 $96 - $139	24 Added 0.04%	64,318 $264,000
Q2 2023 Aug 10, 2023	BUY	$3.06 - $6.38 $19,516 - $40,691	6,378 Added 11.01%	64,294 $381,000
Q1 2023 May 09, 2023	SELL	$3.22 - $4.72 $22,894 - $33,559	-7,110 Reduced 10.93%	57,916 $199,000
Q4 2022 Feb 10, 2023	SELL	$3.03 - $3.79 $8,935 - $11,176	-2,949 Reduced 4.34%	65,026 $228,000
Q3 2022 Nov 10, 2022	BUY	$3.58 - $5.88 $67,529 - $110,914	18,863 Added 38.41%	67,975 $246,000
Q2 2022 Aug 05, 2022	BUY	$5.13 - $9.2 $130,861 - $234,682	25,509 Added 108.08%	49,112 $277,000
Q1 2022 May 12, 2022	BUY	$8.64 - $11.71 $203,929 - $276,391	23,603 New	23,603 $204,000

Others Institutions Holding XBIT

# of Institutions

Shares Held

4.45M

Call Options Held

Put Options Held

View Full List

About XBiotech Inc.

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $77.3M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

More about XBIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. X Biotech Inc. Transaction History